9AG-39305-79090
4 vaccinations
12 coded responses
28 check-ins
12 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 301 / GA
- Registered
- 2021-05-07
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Moderna
-
2021-05-06
Dose 2 — Moderna
-
2021-05-07
Registered in v-safe
-
2021-05-08
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction, Heart rate increased — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Had adverse reaction of elevated heart rate of 117.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Survey response — days 1–6 daily, dose 2MedDRA: Breast tenderness, Lymph node pain, Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Swelling and pain of lymph node in left armpit & breast tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Swollen & tender lymph node under left armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — days 1–6 daily, dose 2MedDRA: Breast tenderness, Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Swollen & tender lymph node in left armpit; tenderness left breastMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
-
2021-06-10
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to workFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-17
-
2021-08-05
Survey response — 3 months, dose 2MedDRA: Dacryostenosis acquired, Migraine, Paranasal sinus hypersecretion, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vertigo, migraine headaches, blocked tear duct and sinus dischargeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-11-05
- 2021-11-23
-
2021-12-02
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-12-11
Dose 3 — Pfizer-BioNTech
- 2021-12-27
-
2022-01-01
Survey response — day 21, dose 3MedDRA: Fatigue, Nasal congestion — Feeling: FairFree text: Fatigue, stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
-
2022-01-15
Survey response — day 35, dose 3MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Congestion, sore throat, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-01-23
Survey response — day 42, dose 3MedDRA: Fatigue, Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Sore throat, fatigue, nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-03-12
- 2022-06-13
-
2022-09-22
Dose 4 — Pfizer-BioNTech
-
2022-10-02
Survey response — day 7, dose 4MedDRA: Adverse reaction — Feeling: GoodFree text: Had extreme for first week after receiving the dose.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-13
-
2022-10-20
Survey response — day 28, dose 4MedDRA: Diarrhoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
-
2022-11-04
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
- 2022-12-24
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Moderna | |
| 2 | 2021-05-06 | Moderna | |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
1 wait over 3 months for a first call
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Had adverse reaction of elevated heart rate of 117.
Systemic reaction (other): Swelling and pain of lymph node in left armpit & breast tenderness
Systemic reaction (other): Swollen & tender lymph node under left armpit
Systemic reaction (other): Swollen & tender lymph node in left armpit; tenderness left breast
Release 9 — day 35, dose 2
Symptoms: Fatigue
Release 9 — 3 months, dose 2
Symptoms: Vertigo, migraine headaches, blocked tear duct and sinus discharge
Release 10 — day 21, dose 3
Symptoms: Fatigue, stuffy nose
Release 10 — day 35, dose 3
Symptoms: Congestion, sore throat, headache
Release 11 — day 42, dose 3
Symptoms: Sore throat, fatigue, nasal congestion
Release 12 — day 7, dose 4
Systemic reaction (other): Had extreme for first week after receiving the dose.
Release 12 — day 28, dose 4
Symptoms: Diarrhea, fatigue
Release 12 — day 42, dose 4
Symptoms: Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dacryolith | ○ | · | ○ |
| SD | Dacryostenosis acquired | ✓ | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Migraine | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Vertigo | ✓ | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Breast tenderness | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release